"The challenge in all settings is to make the
difficult decisions in a way that is defensible, justifiable, ethical, and equitable"So write Nick Freemantle and Suzanne Hill in their introduction to this important discussion on decision making in the reimbursement of pharmaceuticals. Based around a programme supported by the World Health Organization, chapters by leading academics involved in the research tackle such major issues as international pharmaceutical policy, tensions in licensing policies,
priority setting, and relationships between the stakeholders.Chapters include- Development of marketing authorisation
procedures for pharmaceuticals- Interpreting clinical evidence- International…
